Home

די סבל קפיצה teva headquarters us אדון מעדן תקנת הממשלה

Teva Pharmaceutical's US Arm Charged With Price-Fixing
Teva Pharmaceutical's US Arm Charged With Price-Fixing

Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO |  BioSpace
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace

$40 million incentive lures global pharmaceutical giant to Parsippany
$40 million incentive lures global pharmaceutical giant to Parsippany

U.S. approval of Teva drug could help reverse company's migraines - The  Jerusalem Post
U.S. approval of Teva drug could help reverse company's migraines - The Jerusalem Post

Teva Pharmaceuticals Office Photos | Glassdoor
Teva Pharmaceuticals Office Photos | Glassdoor

Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to  North Jersey - WHYY
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY

Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics |  BioSpace
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace

Teva said to 'walk away' from settlement talks in US price-fixing lawsuit |  The Times of Israel
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel

U.S. charges Teva in generic drugs price-fixing probe
U.S. charges Teva in generic drugs price-fixing probe

Teva selects North Jersey site for its new North American headquarters. -  Philadelphia Business Journal
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal

Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) |  Seeking Alpha
Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) | Seeking Alpha

Teva lied about opioid role, New York says | Reuters
Teva lied about opioid role, New York says | Reuters

Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT

Teva Pharmaceuticals Moving U.S. Headquarters To New Jersey
Teva Pharmaceuticals Moving U.S. Headquarters To New Jersey

Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive | Fierce  Pharma
Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive | Fierce Pharma

Teva Stock Is Nothing but Trouble after Legal Issues | InvestorPlace
Teva Stock Is Nothing but Trouble after Legal Issues | InvestorPlace

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New  York Times
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times

Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in  English and Hebrew at their tablet production plant in Jerusalem, on  Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's

Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia

Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA)  | Seeking Alpha
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha

Teva will move North American HQ to New Jersey - Kansas City Business  Journal
Teva will move North American HQ to New Jersey - Kansas City Business Journal

Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The  Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21,  2019 | JewishPress.com
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com

Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook  Warning - WSJ
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ